Evidence map›Paper›PMID 22705493›Full record

ArticlePharmacology, biochemistry, and behavior2012

Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Peter J Winsauer, Catalin M Filipeanu, Evangeline M Bailey, Jerielle L Hulst, Jessie L Sutton

Abstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.Progress in neuro-psychopharmacology & biological psychiatry · 2024
    Article
  3. The relationship between gender and pharmacology.Current research in pharmacology and drug discovery · 2024
    Article
  4. Review
  5. ΔDrug and alcohol dependence · 2021
    Article
  6. Review
  7. Sex, species and age: Effects of rodent demographics on the pharmacology of ∆Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Peter J WinsauerDepartment of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. pwinsa@lsuhsc.edu
Catalin M Filipeanu
Evangeline M Bailey
Jerielle L Hulst
Jessie L Sutton
Louisiana State University Health Sciences Center New Orleans · US

Funding

MENTORING IN CARDIOVASCULAR BIOLOGYP20GM103514 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2012 to 2012
$2.0M
Effects of Chronic THC in AdolescenceR01DA019625 · NIDA · LSU HEALTH SCIENCES CENTER · PI WINSAUER, PETER J · 2006 to 2010
$1.2M
The regulation of cannabinoid receptors in microglial cells during HIV infectionR03DA031596 · NIDA · LSU HEALTH SCIENCES CENTER · PI FILIPEANU, CATALIN · 2011 to 2012
$284k
NIDA NIH HHS DA019625NIDA NIH HHS DA031596NIDA NIH HHS R01 DA019625NIDA NIH HHS R03 DA031596NIGMS NIH HHS 8P20GM103514-10
6 · The paper itself

Abstract

Marijuana abuse during adolescence may alter its abuse liability during adulthood by modifying the interoceptive (discriminative) stimuli produced, especially in females due to an interaction with ovarian hormones. To examine this possibility, either gonadally intact or ovariectomized (OVX) female rats received 40 intraperitoneal injections of saline or 5.6 mg/kg of Δ⁹-THC daily during adolescence, yielding 4 experimental groups (intact/saline, intact/Δ⁹-THC, OVX/saline, and OVX/Δ⁹-THC). These groups were then trained to discriminate Δ⁹-THC (0.32-3.2 mg/kg) from saline under a fixed-ratio (FR) 20 schedule of food presentation. After a training dose was established for the subjects in each group, varying doses of Δ⁹-THC were substituted for the training dose to obtain dose-effect (generalization) curves for drug-lever responding and response rate. The results showed that: 1) the OVX/saline group had a substantially higher mean response rate under control conditions than the other three groups, 2) both OVX groups had higher percentages of THC-lever responding than the intact groups at doses of Δ⁹-THC lower than the training dose, and 3) the OVX/Δ⁹-THC group was significantly less sensitive to the rate-decreasing effects of Δ⁹-THC compared to other groups. Furthermore, at sacrifice, western blot analyses indicated that chronic Δ⁹-THC in OVX and intact females decreased cannabinoid type-1 receptor (CB1R) levels in the striatum, and decreased phosphorylation of cyclic adenosine monophosphate response element binding protein (p-CREB) in the hippocampus. In contrast to the hippocampus, chronic Δ⁹-THC selectively increased p-CREB in the OVX/saline group in the striatum. Extracellular signal-regulated kinase (ERK) was not significantly affected by either hormone status or chronic Δ⁹-THC. In summary, these data in female rats suggest that cannabinoid abuse by adolescent human females could alter their subsequent responsiveness to cannabinoids as adults and have serious consequences for brain development.

Indexed as

AnimalsBlotting, WesternConditioning, OperantCorpus StriatumCyclic AMP Response Element-Binding ProteinData Interpretation, StatisticalDiscrimination LearningDiscrimination, PsychologicalDose-Response Relationship, DrugDronabinolExtracellular Signal-Regulated MAP KinasesFemaleGonadal Steroid HormonesHallucinogensHippocampusOvariectomyCyclic AMP Response Element-Binding ProteinDronabinolExtracellular Signal-Regulated MAP KinasesGonadal Steroid HormonesHallucinogensReceptor, Cannabinoid, CB1

Identifiers

PMID22705493
PMCPMC3402337
OpenAlexW2003051681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.